BSE Live
Dec 09, 16:01Prev. Close
898.80
Open Price
891.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 09, 15:58Prev. Close
897.75
Open Price
895.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
892.80 (25)
| Balance Sheet of Natco Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 35.80 | 35.80 | 36.50 | 36.50 | 36.50 | |
| Total Share Capital | 35.80 | 35.80 | 36.50 | 36.50 | 36.50 | |
| Reserves and Surplus | 7,298.10 | 5,556.50 | 4,665.50 | 4,151.90 | 4,037.00 | |
| Total Reserves and Surplus | 7,298.10 | 5,556.50 | 4,665.50 | 4,151.90 | 4,037.00 | |
| Total Shareholders Funds | 7,333.90 | 5,592.30 | 4,702.00 | 4,191.90 | 4,091.10 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 28.90 | 30.00 | 41.30 | |
| Other Long Term Liabilities | 5.80 | 5.20 | 2.70 | 9.20 | 2.00 | |
| Long Term Provisions | 65.60 | 70.90 | 85.30 | 95.70 | 99.60 | |
| Total Non-Current Liabilities | 71.40 | 76.10 | 116.90 | 134.90 | 142.90 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 273.10 | 363.20 | 159.90 | 389.00 | 255.10 | |
| Trade Payables | 225.10 | 183.30 | 182.40 | 141.20 | 139.50 | |
| Other Current Liabilities | 288.50 | 236.20 | 209.80 | 104.00 | 111.10 | |
| Short Term Provisions | 77.90 | 102.90 | 16.90 | 17.00 | 12.80 | |
| Total Current Liabilities | 864.60 | 885.60 | 569.00 | 651.20 | 518.50 | |
| Total Capital And Liabilities | 8,269.90 | 6,554.00 | 5,387.90 | 4,978.00 | 4,752.50 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 2,409.60 | 2,273.20 | 2,218.20 | 2,158.10 | 1,996.50 | |
| Intangible Assets | 107.20 | 13.50 | 15.60 | 16.10 | 9.40 | |
| Capital Work-In-Progress | 225.30 | 133.90 | 62.80 | 128.70 | 223.40 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 2,742.10 | 2,420.60 | 2,296.60 | 2,302.90 | 2,229.30 | |
| Non-Current Investments | 565.10 | 577.80 | 517.60 | 430.40 | 302.40 | |
| Deferred Tax Assets [Net] | 41.00 | 7.10 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.50 | 0.50 | 0.50 | 0.50 | 27.10 | |
| Other Non-Current Assets | 233.20 | 137.60 | 78.50 | 66.00 | 32.70 | |
| Total Non-Current Assets | 3,581.90 | 3,143.60 | 2,893.20 | 2,799.80 | 2,591.50 | |
| CURRENT ASSETS | ||||||
| Current Investments | 290.00 | 163.90 | 139.90 | 119.60 | 34.60 | |
| Inventories | 642.10 | 596.90 | 616.00 | 697.70 | 769.20 | |
| Trade Receivables | 1,178.20 | 1,076.60 | 793.10 | 575.60 | 399.80 | |
| Cash And Cash Equivalents | 1,856.90 | 864.90 | 412.00 | 100.90 | 262.80 | |
| Short Term Loans And Advances | 9.40 | 9.00 | 10.20 | 10.40 | 12.90 | |
| OtherCurrentAssets | 711.40 | 699.10 | 523.50 | 674.00 | 681.70 | |
| Total Current Assets | 4,688.00 | 3,410.40 | 2,494.70 | 2,178.20 | 2,161.00 | |
| Total Assets | 8,269.90 | 6,554.00 | 5,387.90 | 4,978.00 | 4,752.50 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 50.70 | 58.80 | 55.00 | 52.30 | 42.80 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 552.40 | 379.80 | 277.20 | 388.20 | 223.10 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 3,317.90 | 2,734.70 | 1,725.60 | 888.10 | 1,119.40 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.62 | 5.62 | 5.73 | 5.73 | 5.73 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | 39.90 | 72.10 | |
| Non-Current Investments Unquoted Book Value | 74.70 | 95.90 | 87.30 | 46.10 | 49.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 191.20 | 109.40 | 98.90 | 81.20 | 47.70 | |
| Current Investments Unquoted Book Value | 98.80 | 47.10 | 39.30 | 38.00 | 19.00 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y